Such a master of management, if his health deteriorates, it truly would be a loss to the medical community.
"Is Sisi's new treatment scheduled for tomorrow?" Tang Shun asked.
Yang Ping nodded, "Of course!"
"And then there's Adams, he's resolved the controversy, and his condition is very suited for our current clinical trials, because he has a rare case of adult osteosarcoma, and we need this kind of data," Tang Shun said.
Yang Ping said, "His personal will is strong, there is no controversy, and it's a scarce case, to be included in preliminary clinical trials."
Tang Shun quickly noted it down.
---
Adams knows he doesn't have much time, he can't wait for the second phase clinical trials, even if the second phase can run concurrently with the first phase, there are no slots for him.
